You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
The New Drug Development for Ischemic Stroke in China
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-A-061-Tuesday
- By: WANG, Xiaoliang (Institute of Materia Medica, CAMS, Pharmacology, Beijing, China)
- Co-author(s): Xiaoliang Wang: Pharmacology, Institute of Materia Medica, CAMS, Beijing, China
Ling wang: Pharmacology, Institute of Materia Medica, CAMS, Beijing, China;Pharmacology, Institute of Materia Medica, CAMS, Beijing, China
Shaofeng Xu: Pharmacology, Institute of Materia Medica, CAMS, Beijing, China
Nan Feng: Pharmacology, Institute of Materia Medica, CAMS, Beijing, China - Abstract:
Backgrounds
Ischemic stroke is the most fatal reason for permanent disability all over the world. There are about 8 million ischemic stroke patients and more than 1.5 million incidences each year in China. It is a worldwide challenge to develop a new drug for treatment of ischemic stroke.Aims
Several therapeutic agents were developed in last two.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026